TenaLa DawnRosserMD
Child Neurology • Los Angeles, CAAssistant Professor of Neurology, USC-Keck School of Medicine
Dr. Rosser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
# M
Los Angeles, CA 90027Phone+1 323-361-2940Fax+1 323-361-1109
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Child Neurology, 1999 - 2002- Children's National HospitalResidency, Pediatrics, 1996 - 1999
University of North Carolina at Chapel Hill School of MedicineClass of 1996
Certifications & Licensure
DC State Medical License 1997 - Present
CA State Medical License 2004 - 2026
MD State Medical License 2002 - 2005
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Start of enrollment: 2013 May 15
- MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 Start of enrollment: 2014 Jun 01
- Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSafety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder.Jonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, Natalie K Boyd, Benjamin N Vogel
American Journal of Medical Genetics. Part A. 2024-05-01 - Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.Ashley Cannon, Kavita Y Sarin, Andrea K Petersen, Dominique C Pichard, Pamela L Wolters
Clinical Trials. 2024-02-01 - Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.Pamela L Wolters, Nour Al Ghriwati, Melissa Baker, Staci Martin, Dale Berg
Clinical Trials. 2024-02-01
Press Mentions
New State-of-the-Art Neurological Institute Outpatient Center Opens at Children's Hospital Los AngelesApril 21st, 2021
An Update on the Central Nervous System Manifestations of Tuberous Sclerosis ComplexApril 13th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
